Home » Headlines » Currently Reading:

Morning Headlines 6/21/18

June 20, 2018 Headlines No Comments

GoodRx, a service for finding the best price on prescription drugs, is in sale talks for up to $3 billion

Prescription drug comparison pricing company GoodRx is reportedly in talks with several companies, including McKesson, to sell its assets for between $1.5 billion and $3 billion.

Amazon, Berkshire Hathaway and JPMorgan Chase Appoint Dr. Atul Gawande as Chief Executive Officer of Their Newly-Formed Company to Address U.S. Employee Healthcare

Surgeon, professor, and journalist Atul Gawande, MD will become CEO of Amazon, Berkshire Hathaway, and JPMorgan Chase’s new healthcare venture, effective July 9.

Special congressional panel to scrutinize VA’s medical records overhaul

Rep. Phil Roe, MD (R-TN) and Tim Walz (D-MN) will create a House Committee on Veterans’ Affairs subcommittee that will keep a close eye on the VA’s EHR overhaul and other major IT projects.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • Woodstock Generation: Gotta love those O'Jays, hot pink suits et al. In other words, gotta love doo-wop, soul, and all those related sounds t...
  • Vaporware?: JTR, Cerner is re-tooling itself from a software company (sic) into a service company. The company needs a place to put ...
  • Dave Butler: Many similar issues that I've found as well during my time with provider groups. The EHRs screen can be really busy and ...
  • Justa Trench Rat: Nice to see Cerner continuing with their new campus. I am sure our implementation of their highly questionable revenue ...
  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links